Compile Data Set for Download or QSAR
maximum 50k data
Found 101 Enz. Inhib. hit(s) with all data for entry = 9468
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468299((2S,4R)-1-(2-(3- acetyl-1H- pyrazolo[3,4- e]pyridi...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468558((2S,4R)-1-(2-(3- acetyl-1H-indol-1- yl)acetyl)-N-(...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468565((2S,4R)-1-(2-(3- acetyl-1H-indazol- 1-yl)acetyl)-N...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468571(5-bromo-1-(2- ((2S,4R)-2-(3-(4- chloro-1H- benzo[d...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468575((1R,3S,5R)-2-(2-(3- acetyl-1H-indazol- 1-yl)acetyl...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468577(1-(2-((2S,4R)-2-(3- (1H- benzo[d]imidazol- 5-yl)-2...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468578((2S,3R)-2-(2-(3- acetyl-1H-indol-1- yl)acetamido)-...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468579(1-(2-((2S,4R)-2-(2'- chloro-2-fluoro-5'- ((E)-1- (...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468580(1-(2-((2S,4R)-2-(3- (4-chloro-2- (trifluoromethyl)...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468584(1-(2-((2S,4R)-4- fluoro-2-(2-fluoro- 3-(2-methyl-1...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468585(1-(2-((2S,4R)-2-(3- (4-chloro-2-oxo- 2,3-dihydro-1...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468588(1-(2-((2S,4R)-2-(3- (4-chloro-2-methyl- 1H- benzo[...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468589(1-(2-((2S,4R)-2-(3- (3-cyano-1H- indazol-5-yl)-2- ...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468593(1-(2-((2S,4R)-2-(3- (4-chloro-2-((S)-1- hydroxyeth...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468601(1-(2-((2S,4R)-2-(3- (4-chloro-1H- indazol-5-yl)-2-...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468614(1-(2-((2S,4R)-2-(3- (2-acetyl-7-chloro- 1H- benzo[...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468615(1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- y...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468616(1-(2-((2S,4R)-2-(3- (4-chloro-1-methyl- 1H- benzo[...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468617((2S,4R)-1-(2-(3- carbamoylphenyl) acetyl)-N-(2'-ch...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468620((2S,4R)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-1-(...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468621(1-(2-((2S,4R)-4- fluoro-2-(2-fluoro- 3-(1H-indol-6...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468622(1-(2-((2S,4R)-2-(3- (2-amino-7-chloro- 1H- benzo[d...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468623(1-(2-((2S,4R)-2-(3- (7-chloro-1H- benzo[d]imidazol...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468624(1-(2-((2S,4R)-4- fluoro-2-(2-fluoro- 3-(1H-indazol...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468625(1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468628(1-(2-((2S,4R)-2-(3- (3-cyano-1H- indazol-6-yl)-2- ...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468629(1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- y...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468630(1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468631(1-(2-((2S,4R)-2-(3- (3-acetyl-1H-indol- 6-yl)-2- f...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468633(1-(2-((2S,4R)-4- fluoro-2-(2-fluoro- 3-(pyrazolo[1...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468634(6-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- y...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468635(1-(2-((2S,4R)-2-(5'- carbamoyl-2'- chloro-2- fluor...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468636(1-(2-((2S,4R)-2- ((6-bromopyridin- 2-yl)carbamoyl)...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468638((2S,4R)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-1-(...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468639((2S,4R)-N-(2'- chloro-2- fluorobiphenyl-3- yl)-4-f...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468640(1-(2-((2S,4R)-2-(3- (7-chloro-2-fluoro- 1H- benzo[...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468641(1-(2-((2S,4R)-2- ((2'-chloro-2- fluoro-[1,1'- biph...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468642(1-(2-((2S,4R)-2-(3- (7-chloro-1H- benzo[d]imidazol...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468643(1-(2-((2S,4R)-2-(3- (7-chloro-1H- indazol-6-yl)-2-...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468644((2S,4R)-1-(2-(3- bromo-5- methoxyphenyl) acetyl)-N...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468645(1-(2-((2S,4R)-2-(5'- carbamoyl-2'- chloro-2- fluor...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468646(1-(2-((2S,4R)-2-(3- (7-chloro-1H- imidazo[4,5- b]p...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468647(US10807952, Cmp No. 51 | tert-butyl 2-(3'- ((2S,4R...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468648(1-(2-((2S,4R)-2-(3- (benzo[d]thiazol-5- yl)-2- flu...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468649(1-(2-((2S,4R)-2-(3- (benzo[d]thiazol-6- yl)-2- flu...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468652(1-(2-((2S,4R)-2-(3- (benzo[d]oxazol-6- yl)-2- fluo...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468653(1-(2-((2S,4R)-2-(3- (benzo[d]oxazol-5- yl)-2- fluo...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM468655(1-(2-((2S,4R)-2-(3- (5-chloro-3-oxo- 1,2,3,4- tetr...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM386755((2S,4R)-1-(2-(1- acetyl-6-(2- methylpyrimidin- 5-y...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor D(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM386756((2S,4R)-1-(2-(1- acetyl-6-(2- methylpyrimidin- 5-y...)
Affinity DataIC50: <1.00E+3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 101 total ) | Next | Last >>
Jump to: